e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Airway disease: recent discoveries
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Using fractional exhaled nitric oxide level to differentiate asthma–COPD overlap syndrome from COPD
V. Taskin (KONYA, Turkey), F. Kanat (KONYA, Turkey), M. Suerdem (KONYA, Turkey), N. Gurel (KONYA, Turkey), B. Tulek (KONYA, Turkey)
Source:
International Congress 2018 – Airway disease: recent discoveries
Session:
Airway disease: recent discoveries
Session type:
Thematic Poster
Number:
4419
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Taskin (KONYA, Turkey), F. Kanat (KONYA, Turkey), M. Suerdem (KONYA, Turkey), N. Gurel (KONYA, Turkey), B. Tulek (KONYA, Turkey). Using fractional exhaled nitric oxide level to differentiate asthma–COPD overlap syndrome from COPD. 4419
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Two sites of airway obstruction identified by post-bronchodilation change of exhaled nitric oxide in COPD patients
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
The influence of asthma and COPD exacerbation on exhaled mitric oxide (FE
NO
)
Source: Eur Respir J 2004; 24: Suppl. 48, 409s
Year: 2004
Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD
Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019
Year: 2019
Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma
Source: Eur Respir J 2008; 32: 344-349
Year: 2008
Stability of exhaled nitric oxide (F
E
NO) in patients with severe, steroid-dependent asthma
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008
Exercise training and exhaled nitric oxide (eNO) in COPD patients of different severity
Source: Eur Respir J 2001; 18: Suppl. 33, 222s
Year: 2001
Comparison of three different exhaled nitric oxide analyzers in asthma and COPD
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
Investigation of nitric oxide level in the exhaled breath condensate in asthma and COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 281s
Year: 2005
Exhaled nitric oxide (FeNO) in relation to exacerbation of childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
Is exhaled nitric oxide (eNO) an indipendent outcome measure in chronic stable asthma?
Source: Eur Respir J 2002; 20: Suppl. 38, 196s
Year: 2002
The relationship between exhaled nitric oxide and airway hyperresponsiveness in patients with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 366s
Year: 2007
Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Correlation between exhaled nitric oxide, airway hyper responsiveness and pulmonary function data in patients with suspected asthma
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
Usefulness of fractional exhaled nitric oxide (FeNO) for early diagnosis of asthma in patients with nonspecific respiratory symptoms
Source: Annual Congress 2009 - From cough to sound analysis of breathing
Year: 2009
Can fractional exhaled nitric oxide be useful to differentiate asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) from COPD-only
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
In current smokers fraction of exhaled nitric oxide is not associated with asthma symptoms
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010
Exhaled nitric oxide predicts response to treatment in COPD patients with exacerbation
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008
The relationship between fractional exhaled nitric oxide and asthma symptom scores in patients on mepolizumab
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
High levels of fractional exhaled nitric oxide (FeNO) in severe oral steroid-dependent asthma are associated with eosinophilia and atopy
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept